Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — December 2018

Planlagt Fastgjort Låst Flyttet Genmab
1.5k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #777

    Dr. Shahzad Raza, MD of Saint Luke's Cancer Institute talks about a trial investigating the treatment of newly diagnosed multiple myeloma with a four drug combination of Daratumumab, Revlimid, Dexamethasone and Velcade. SC. https://www.youtube.com/watch?v=vCdZQnyCxOk

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #778

      Dr. Mike Thompson, MD, PhD of Aurora Health Care talks about a trial investigating Daratumumab, Velcade, Dexamethasone with or without Venetoclax https://www.youtube.com/watch?v=gqFnHwkGtMY ("adding venetoclax to the backbone of standard of care")

      1 Reply Last reply
      0
      • Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktør
        wrote on sidst redigeret af
        #779

        Just a moment...

        favicon

        (www.proinvestor.com)

        1 Reply Last reply
        0
        • P Offline
          P Offline
          peter12
          wrote on sidst redigeret af
          #780

          Dara er priseffektiv i RRMM https://onlinelibrary.wiley.com/doi/abs/10.1002/ajh.25372

          1 Reply Last reply
          0
          • P Offline
            P Offline
            polle1
            wrote on sidst redigeret af
            #781

            God morgen 🙂

            1 Reply Last reply
            0
            • bongobobB Offline
              bongobobB Offline
              bongobob
              wrote on sidst redigeret af
              #782

              peter12. Ikke kun pris effiktiv men også langt færre bivirkninger: " Overall tolerability is
              worse in patients on pomalidomide, who experience higher rates of central nervous system
              effects, diarrhea, cramping, rashes, and a more significant impact on blood counts."

              1 Reply Last reply
              0
              • bongobobB Offline
                bongobobB Offline
                bongobob
                wrote on sidst redigeret af
                #783

                Det er en meget gammel sandhed , men vigtig

                1 Reply Last reply
                0
                • R Offline
                  R Offline
                  Raffles
                  wrote on sidst redigeret af
                  #784

                  New DARA-study, phase 4!, in Indian participants https://clinicaltrials.gov/ct2/show/NCT03768960?term=Daratumumab+OR+Ofatumumab+OR+Tisotumab&lupd_s=12%2F01%2F2018&lupd_e=12%2F10%2F2018&rank=1

                  1 Reply Last reply
                  0
                  • H Offline
                    H Offline
                    Hen
                    wrote on sidst redigeret af
                    #785

                    Genmab har fået en løftet anbefaling fra tyske Deutsche Bank, som har løftet anbefalingen til køb fra tidligere hold. Det skriver Bloomberg mandag morgen. Den løftede anbefaling er umiddelbart ikke ledsaget af noget kursmål. Kilde: Aktiefokus.

                    1 Reply Last reply
                    0
                    • R Offline
                      R Offline
                      Raffles
                      wrote on sidst redigeret af
                      #786

                      Rafael Fonseca, MD, Five medical ways to optimize the value of care. Good for patients, payers and good medicine. 1. Right treatment, 2. Durable initial remissions re likely best-value, 3. Avoid unnecessary exposure to toxicity….https://twitter.com/Rfonsi1/status/1071865959470616576

                      1 Reply Last reply
                      0
                      • J Offline
                        J Offline
                        JKY_VH
                        wrote on sidst redigeret af
                        #787

                        link til skrivet fra Hen https://www.nordnet.dk/mux/web/analys/nyheter/visaNyhet.html?itemid=507020013&sourcecode=ddk

                        1 Reply Last reply
                        0
                        • H Offline
                          H Offline
                          Hen
                          wrote on sidst redigeret af
                          #788

                          Link virker vist ikke. Her er link til Aktiefokus: http://www.aktiefokus.dk/customers/landbobanken.dk/morningcocktail/Default.aspx?id=1

                          1 Reply Last reply
                          0
                          • BulderB Offline
                            BulderB Offline
                            Bulder
                            wrote on sidst redigeret af
                            #789

                            Men Ritzau skriver at Deutsche har nyt kursmål på 1250

                            1 Reply Last reply
                            0
                            • BulderB Offline
                              BulderB Offline
                              Bulder
                              wrote on sidst redigeret af
                              #790

                              Kunne tyde på at de er blevet lidt mere sikre på at dara trænger igennem i 1. linje i US.

                              1 Reply Last reply
                              0
                              • BulderB Offline
                                BulderB Offline
                                Bulder
                                wrote on sidst redigeret af
                                #791

                                Peaksale over 7 mia $

                                1 Reply Last reply
                                0
                                • J Offline
                                  J Offline
                                  JKY_VH
                                  wrote on sidst redigeret af
                                  #792

                                  linket virker udmærket hos mig

                                  1 Reply Last reply
                                  0
                                  • BulderB Offline
                                    BulderB Offline
                                    Bulder
                                    wrote on sidst redigeret af
                                    #793

                                    er det ikke fordi du er kunde og logget på?

                                    1 Reply Last reply
                                    0
                                    • B Offline
                                      B Offline
                                      bikube
                                      wrote on sidst redigeret af
                                      #794

                                      Deutsche udnævner Novo til favoritaktie og løfter vurdering af Genmab. Fra MedWatch på PI´s nyheder kl 9.59. Det er en lidt udvidet version.

                                      1 Reply Last reply
                                      0
                                      • Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktør
                                        wrote on sidst redigeret af
                                        #795

                                        Just a moment...

                                        favicon

                                        (www.proinvestor.com)

                                        1 Reply Last reply
                                        0
                                        • DarvinD Offline
                                          DarvinD Offline
                                          Darvin
                                          wrote on sidst redigeret af
                                          #796

                                          Et link til en spansk side, hvor Mateo kommer lidt mere omkring mht Dara og fremhæver Dara. Hun er her særdeles positiv og bemærker 1 at 29 pct dør et år efter diagnosen. 2 at Dara giver øget og meget mere holdbar respons. 3 at hun tror på en median på 5 år. http://www.gacetamedica.com/especializada/daratumumab-se-posiciona-en-todas-las-lineas-reforzando-su-perfil-clinico-en-mm-NN1843708

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger